Novo Nordisk A/S sell kostojunior
Start price
07.11.14
/
50%
€35.32
Target price
01.12.14
€33.33
Performance (%)
4.32%
End price
01.12.14
€36.85
Summary
This prediction ended on 01.12.14 with a price of €36.85. With a performance of 4.32%, the SELL prediction by kostojunior for Novo Nordisk A/S was trending in the wrong direction kostojunior has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S | - | - | - | - |
| iShares Core DAX® | -1.816% | -2.419% | 12.070% | 14.356% |
| iShares Nasdaq 100 | 4.333% | 8.073% | 32.493% | 59.393% |
| iShares Nikkei 225® | 0.657% | 1.234% | 2.682% | 5.342% |
| iShares S&P 500 | 2.968% | 4.613% | 26.496% | 49.719% |
Comments by kostojunior for this prediction
In the thread Novo Nordisk A/S diskutieren
Chart
short ab 36 euro
ziel 33,xx
kj
............................................................
(Vom Mitglied beendet)